Use of contrast-enhanced mammography for diagnosis of breast cancer

被引:0
|
作者
Fischer, Uwe [1 ]
Diekmann, Felix [2 ]
Helbich, Thomas [3 ]
Preibsch, Heike [4 ]
Puesken, Michael [5 ]
Wenkel, Evelyn [6 ,7 ]
Wienbeck, Susanne [8 ,9 ]
Fallenberg, Eva Maria [10 ,11 ]
机构
[1] Diagnost Brustzentrum Gottingen, Gottingen, Germany
[2] Krankenhaus St Joseph Stift, Inst Radiol Diagnost, Bremen, Germany
[3] Med Univ Wien AKH WIEN, Abt Allgemeine & Padiatr Radiol, Univ Klin Radiol & Nukl Med, Vienna, Austria
[4] Univ Klinikum Tubingen, Diagnost & Intervent Radiol, Tubingen, Germany
[5] Uniklin Koln, Inst Diagnost & Intervent Radiol, Cologne, Germany
[6] Friedrich Alexander Univ Erlangen Nurnberg FAU, Med Fak, Erlangen, Germany
[7] Radiol Munchen, Munich, Germany
[8] Radiol Schwarzer Bar MVZ, Hannover, Germany
[9] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany
[10] Tech Univ Munchen TUM, Inst Diagnost & Intervent Radiol, Sch Med, Munich, Germany
[11] Tech Univ Munchen TUM, Klinikum Rechts Isar, Munich, Germany
来源
RADIOLOGIE | 2023年 / 63卷 / 12期
关键词
Breast cancer; Cancer screening; Radiological imaging; Iodinated contrast media; Patient education; SPECTRAL MAMMOGRAPHY; MRI; WOMEN; RISK;
D O I
10.1007/s00117-023-01222-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundContrast-enhanced mammography (CEM) is an imaging method that is able to improve visualization of intramammary tumors after peripheral venous administration of an iodine-containing contrast medium (ICM). Objectives and methodsThe current significance of CEM is discussed. ResultsStudies were able to show an advantage of CEM in the diagnosis of breast cancer compared to mammography, especially for women with dense breasts. Indications for CEM currently depend on the availability of magnetic resonance imaging (MRI). If MRI is available, CEM is indicated in those cases when MRI cannot be performed. Use of CEM for breast cancer screening is currently viewed critically. This view can change when results and updated assessments of large CEM studies in Europe and USA become available. Patients must be informed about the use of an ICM. As ICM administration for CEM is carried out in a similar manner to established imaging methods, the authors expect the use of ICM for CEM to be unproblematic as long as general contraindications are adhered to. ConclusionsIn the future, CEM could have greater importance for the diagnosis of breast cancer, as this imaging method has diagnostic advantages compared to conventional mammography. A great advantage of CEM is its availability. For those who use breast MRI, CEM is helpful when MRI is not feasible due to contraindications or other reasons.
引用
收藏
页码:916 / 924
页数:9
相关论文
共 50 条
  • [41] Contrast-Enhanced Mammography for Women with Palpable Breast Abnormalities
    Amir, Tali
    Pinker, Katja
    Sevilimedu, Varadan
    Hughes, Mary
    Keating, Delia T.
    Sung, Janice S.
    Jochelson, Maxine S.
    ACADEMIC RADIOLOGY, 2024, 31 (04) : 1231 - 1238
  • [42] Contrast-enhanced Mammography and Breast MRI: Friends or Foes?
    Lobbes, Marc B. I.
    Jochelson, Maxine S.
    Neeter, Lidewij M. F. H.
    Nelemans, Patricia J.
    RADIOLOGY, 2023, 307 (01)
  • [43] Contrast-enhanced Mammography: An Emerging Modality in Breast Imaging
    Bahl, Manisha
    RADIOLOGY, 2022, 302 (03) : 582 - 583
  • [44] BIRADS 4 breast lesions: comparison of contrast-enhanced spectral mammography and contrast-enhanced MRI
    Yasin R.
    El Ghany E.A.
    Egyptian Journal of Radiology and Nuclear Medicine, 50 (1):
  • [45] Feasibility of contrast-enhanced mammography in women with breast implants
    Hogan, Molly P.
    Amir, Tali
    Mango, Victoria L.
    Morris, Elizabeth A.
    Jochelson, Maxine S.
    CLINICAL IMAGING, 2023, 93 (31-33) : 31 - 33
  • [46] Contrast-enhanced dual-energy digital mammography in the evaluation of breast cancer
    Awad, Fatma Mohamed
    Ismaeil, Hanaa
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2014, 45 (02): : 591 - 595
  • [47] Breast cancer screening in patients with intermediate risk using contrast-enhanced mammography
    Lobbes, Marc B. I.
    EUROPEAN RADIOLOGY, 2023, 33 (12) : 8407 - 8409
  • [48] Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes
    Luczynska, Elzbieta
    Piegza, Tomasz
    Szpor, Joanna
    Heinze, Sylwia
    Popiela, Tadeusz
    Kargol, Jaromir
    Rudnicki, Wojciech
    BIOMEDICINES, 2022, 10 (10)
  • [49] Association between lesion enhancement and breast cancer in contrast-enhanced spectral mammography
    Boy, Fatma Nur Soylu
    Goksu, Kamber
    Tasdelen, Iksan
    ACTA RADIOLOGICA, 2023, 64 (01) : 74 - 79
  • [50] Breast cancer screening in patients with intermediate risk using contrast-enhanced mammography
    Marc B. I. Lobbes
    European Radiology, 2023, 33 : 8407 - 8409